| Literature DB >> 21218053 |
P Chattopadhyay1, P Chaudhury, A K Wahi.
Abstract
Ischemic and reperfusion injury leads to necrosis and apoptosis. Mitochondrial enzymes and antiapoptotic gene plays an important role in necrosis and apoptosis. The aim of this study was to investigate the role of Bcl-2 expression in alternations in mitochondrial energy regulation during hepatic ischemia and reperfusion and role in necrosis and apoptosis. Total 12 Wistar rats were divided into sham-operated control group (I) and ischemia and reperfusion group (II). Mitochondrial tri carboxylic acid cycles marker enzymes, respiratory marker enzymes, apoptotic cells, necrotic cells and Bcl-2 expression was measured. Number of necrotic and apoptotic cells were increased in ischemic and reperfusion group with reducing tri carboxylic acid cycles marker enzymes, respiratory marker enzymes and decreasing of Bcl-2 expression. On the basis of our findings it may be concluded that suppression of Bcl-2 gene, inhibition of tri carboxylic acid cycles and respiration rate, adenosine tri phosphate production in mitochondria is a pathophysiological consequences which provides a clue for necrosis and apoptosis in hepatic ischemic and reperfusion injury.Entities:
Keywords: Bcl-2 gene; liver ischemia; mitochondrial enzymes; reperfusion injury
Year: 2010 PMID: 21218053 PMCID: PMC3013573 DOI: 10.4103/0250-474X.73913
Source DB: PubMed Journal: Indian J Pharm Sci ISSN: 0250-474X Impact factor: 0.975
MITOCHONDRIAL TCA AND RESPIRATORY MARKER ENZYMES IN LIVER AFTER ISCHEMIA REPERFUSION
| Groups | MDH | SDH | α- KGDH | NADH | cyt-C |
|---|---|---|---|---|---|
| Sham-operated (Group I) | 319.11±14.0 | 247.44±24.8 | 74.20±5.8 | 121.47±9.7 | 0.34±0.02 |
| I/R Injury (Group II) | 198.11±24.2a | 107.02±15.1 | 24.51±9.0a | 60.44±7.5a | 0.15±0.04a |
Results are expressed as mean±SD (n=6).
P<0.05a Comparison are made between sham operated control (group I) with I/R injury (group II).
expressed as nmol of NADH oxidized per min per mg protein for MDH.
expressed as nmol of succinate oxidized per min per mg protein for SDH.
expressed as nmol of ferrocyanide formed per hour per mg protein for aKGDH.
expressed as nmol of NADH oxidized per min per mg protein for NADH dehydrogenase.
expressed as nmol per min per mg of protein for cytochrome-C-oxidases.
Fig. 1Bcl-2 gene expression by reverse transcriptase polymerase chain reaction
(a) Representative photograph of the expression of Bcl-2 gene using RTPCR analysis. Bcl-2 gene expressed at 234 bp and housekeeping gene was glyceraldehydes-3-phosphate dehydrogenase expressed at 510 bp. Lane M: marker, Lane 1: sham-operated control group (I), Lane 2: I/R rat (II). (b) the expression of Bcl-2 gene after 1 h ischemia followed by 3 h reperfusion. Data are expressed as the mean±SD
Fig. 2Expression of Bcl-2 protein by Western blot methods
(a) Representative photograph of the expression of Bcl-2 protein using western blot analysis. Lane 1: Sham-operated control group (I), Bcl-2 was strongly expressed in the sham-operated liver. Lane 2: Ischemic and reperfused liver (II), Expression level was decreased after 1 h ischemia followed by 3 h reperfusion in group I. (b) The expression of Bcl-2 protein after 1 h ischemia and 3 h reperfusion. Data are expressed as the mean ±SD
APOPTOTIC AND NECROTIC CELLS AND ATP LEVELS IN LIVER AFTER ISCHEMIA REPERFUSION
| Group | % of Necrotic cells | % of Apoptotic cells | % of ATP production |
|---|---|---|---|
| Sham-operated control Group (I) | 1.06±0.2 | 1.30±0.5 | 100 (Base value) |
| Ischemia and reperfusion Group (II) | 28.44±4.7a | 14.44±6.0a | 12.49 |
Mean±SD, n=6. aComparison are made between sham-operated control (group I) with I/R injury (group II).
Fig. 3Fluorescence microscopy shows viable cells and apoptosis cell Fluorescence microscopy of hepatocytes stained with ethidium bromide and acridine orange (100 mg/ml). Viable cells observed with green nuclear fluorescence and apoptotic cells containing an orange nucleus (marked arrow) and exhibiting chromatin condensation. Magnification X 200. (a) Sham-operated group; (b) Ischemia followed by reperfusion group (II).